MaxWell Biosystems
MaxWell Biosystems provides solutions to advance basic neuroscience research and accelerate preclinical drug discovery.
MaxWell Biosystems has raised €3.7M across 1 funding round from 1 investor, most recently a Series A round in Dec 2020. Based in Basel, Switzerland; founded 2016; active in Healthtech. Data as of 28 Oct 2026.
Total raised
€3.7M
€3,708,511
Funding rounds
1
Investors
1
distinct backers
Active since
2020-12
latest 2020-12
Funding by year
EUR raised per yearMaxWell Biosystems — funding by year — interactive chart.
Data table
| MaxWell Biosystems — funding by year | |
|---|---|
| 2020 | €3.7M |
Signals
High confidenceRaise-next likelihood8
base rate 44% for Series A
- ▼ Dormant (no round in 3+ cohort gaps)
- ▼ Low backer re-investment
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2020-12-17 | Series A | €3.7M | Sensirion | View deal → |
Investors
1Related news
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- CMR Surgical€1.5BUK · Healthtech
- Roivant Sciences€1.1BSwitzerland · Healthtech
- Neko Health€924MSweden · Healthtech
- Climeworks€919MSwitzerland · Cleantech
Global coverage: FundingData